악성 신경 교종 환자에서 High-Activity Indium-192를 이용한 종양내삽입 방사선 치료의 임상분석
Clinical Analysis of Sterotactic Brachytherapy with High-Activity Iridium-192 Sources for Treatment of Malignant Astrocytomas
소속 상세정보
이선회
손은익/이장철/김동원/임만빈/김인홍/최태진/김옥배
KMID : 0359819930220020252
Abstract
Interstitial irradiation using high-activity Iridium-192 sources was studied clinically to treat supratentorial malignant astrocytomas (including glioblastoma multifrome). As of 1988, in attempt to define the efficacy of this technique in
patients
with
more extensive disease, we treated patients less rigid selection criteria.
15 eligible patients have been approached and ten have accepted randomization for follow-up study over two years. Pathology was anaplastic astrocytoma in 5 patients, glioblastoma multiforme in 5 patients. Mean survival of patients treated with
this
procedure was 18.4 months. Continued investigation will determine which patient may benefit from this techique.
키워드
원문 및 링크아웃 정보
등재저널 정보